Cigna Corporation (CI) Cash Flow Statement

The negative OCF in Q2 2026, despite net income of $1.7B, suggests that cash generation is not directly tracking earnings, likely due to working capital swings in pharmacy payables and receivables. The OCF/NI ratio of -0.25 in Q2 2026 versus 4.98 in Q4 2025 highlights the lumpy nature of cash flows, which may indicate that reported earnings are not yet translating into cash at the same pace. Investors should monitor whether this volatility is a seasonal pattern or a sign of structural pressure on float.

The steady climb in claims paid, particularly the jump to $66.9B in Q4 2025, indicates that Cigna is experiencing higher cash outflows for medical services, which may reflect increased utilization or higher unit costs. While the loss ratio in the income statement showed volatility, the cash flow data suggests that the company is paying out more in claims, which could pressure future margins if not offset by premium increases. This trend warrants close monitoring for any signs of adverse medical cost trends.

The investment portfolio cash flows are small relative to the company's overall cash generation, indicating that Cigna does not rely on portfolio liquidation to fund operations. The net sales in Q2 2026 may be a tactical rebalancing rather than a strategic shift. Given the low investment income contribution noted in the income statement analysis, the portfolio's role in cash flow is likely to remain secondary.

In Q2 2026, Cigna paid $409M in dividends and repurchased $280M in stock, while OCF was negative. This suggests that the company is funding shareholder returns through other means, such as existing cash reserves or debt, which may not be sustainable if OCF remains weak. However, the $6.1B OCF in Q4 2025 shows that the company can generate substantial cash in some quarters, so the Q2 shortfall may be temporary. Investors should monitor whether the pace of buybacks aligns with cash generation over the longer term.

The divergence between net income and operating cash flow, particularly in Q2 2026, suggests that reported earnings may be supported by non-cash accruals, such as reserve releases, which were noted in the income statement analysis. The negative OCF in Q2 2026, despite positive net income, implies that cash generation is lagging, which could be a red flag if it persists. This pattern warrants further investigation into the quality of earnings and the sustainability of cash flows.